Reversing Heart Disease: the Dean Ornish Approach

The Cutting Edge of Health and Wellness Today
Friday, September 11, at 2 PM Pacific

Reversing Heart Disease: the Dean Ornish Approach

Today, I am delighted to bring back to our program Dr. Ben Brown, who is now the Medical Director of Ornish Lifestyle Medicine in Sausalito, California. Dr. Ornish pioneered and researched the unique diet and life-style changes that has enabled thousands of patients with heart disease to recover their health. Dr. Brown will review this program and help us to understand how to use this information to improve our own heart health. Please join us for this important broadcast.
[Read more…]


Chelation therapy in TACT: Daring to challenge dogma (and suspend disbelief)

By Eric J Topol MD
Director, Scripps Translational Science Institute
The Gary and Mary West Chair of Innovative Medicine
Chief Academic Officer, Scripps Health
La Jolla, CA

Originally posted at on May 26,2013

Although suffering from significant imperfections, the TACT trial is a daring step toward a better understanding of how chelation therapy might affect heart disease. It seemed like a crazy notion in 2003—when the NIH invested $31 million to fund the research—but the consistent and notable reduction of a spectrum of clinical end points indicates that maybe something important—and controversial—is happening.

I’d like to review with you one of the most controversial trials in cardiovascular medicine that has been published in a long time: the TACT trial of over 1700 patients who had a prior myocardial infarction and then were getting chelation therapy.

The chelation therapy was given over 30 weeks, every week. It wasn’t just EDTA but also a mixture of various vitamins, potentially what you could consider antioxidants, that were added to the solution. It was given for 30 weeks consecutively, with another series of infusions given several weeks after that. And this was conducted at various sites. It took from 2003 to 2011—eight years—before it was completed.

Read the rest of this transcript or listen to Dr. Topol discuss the TACT trial…….

Look for upcoming articles by Gordon Medical practitioners on chelation as practiced at GMA.


Metabolic Syndrome: What Is It, and What Can You Do About It?

Elizabeth Large, NDBY Elizabeth Large, ND

Metabolic syndrome is called a syndrome rather than a disease because it refers to a group of risk factors that occur together and which increase the risk for coronary artery disease, peripheral artery disease, type 2 diabetes and stroke.  It is believed to effect approximately 25% or 47 million of the US population.  Risk factors for metabolic syndrome include: genetics, hypertension, insulin resistance, hyperlipidemia and obesity, especially increased abdominal girth. To determine if you suffer from metabolic syndrome, most doctors look for the presence of three or more of these components:

  • Central or abdominal obesity (measured by waist circumference):
    • Men – Greater than 40″
    • Women – Greater than 35″
  • Fasting blood triglycerides greater than or equal to 150 milligrams per deciliter of blood (mg/dL)
  • Blood HDL cholesterol:
    • Men – Less than 40 mg/dL
    • Women – Less than 50 mg/dL
  • Blood pressure greater than or equal to 130/85
  • Fasting glucose greater than or equal to 100 mg/dL [Read more…]